• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲莱姆病监测概况。

The Landscape of Lyme Borreliosis Surveillance in Europe.

机构信息

P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.

Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom.

出版信息

Vector Borne Zoonotic Dis. 2023 Apr;23(4):142-155. doi: 10.1089/vbz.2022.0067.

DOI:10.1089/vbz.2022.0067
PMID:37071402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10122255/
Abstract

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and/or dashboards and to compare the information available for various countries. We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland. Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries. The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.

摘要

莱姆病(LB)是欧洲最常见的蜱传疾病,由于蜱栖息地的扩大,LB 的发病率正在上升。然而,欧洲大陆的 LB 监测情况差异很大,对于那些有公开可用数据的国家,很难理解各国之间发病率的差异。我们的研究目的是总结 LB 监测的公开可用数据,形式为监测报告和/或仪表板,并比较各国的可用信息。我们在欧盟、欧洲经济区、英国、俄罗斯和瑞士确定了 LB 监测的公开可用数据(在线仪表板和监测报告)。在所研究的 36 个国家中,有 28 个国家开展了 LB 监测;23 个国家有监测报告,10 个国家有仪表板。一般来说,仪表板的数据比监测报告更详细,但报告涵盖的时间周期更长。大多数国家都有 LB 年度病例、发病率、年龄和性别分层的 LB 数据;表现;以及区域数据。LB 病例定义在各国之间存在显著差异。该研究突出了 LB 监测系统的巨大差异,包括代表性、病例定义、可用数据类型,这些可能会阻碍国家之间的数据比较和准确确定疾病负担,以及国家内部的风险群体。在国家之间标准化病例定义将是一个有用的第一步,使国家之间能够进行比较,并有助于认识到欧洲 LB 的真实负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f46/10122255/c2a3e166bdb2/vbz.2022.0067_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f46/10122255/c2a3e166bdb2/vbz.2022.0067_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f46/10122255/c2a3e166bdb2/vbz.2022.0067_figure1.jpg

相似文献

1
The Landscape of Lyme Borreliosis Surveillance in Europe.欧洲莱姆病监测概况。
Vector Borne Zoonotic Dis. 2023 Apr;23(4):142-155. doi: 10.1089/vbz.2022.0067.
2
Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).欧洲国家监测系统(2005-2020 年)的莱姆病螺旋体病发病率。
Vector Borne Zoonotic Dis. 2023 Apr;23(4):156-171. doi: 10.1089/vbz.2022.0071.
3
Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020).欧洲莱姆病的发病率:系统评价(2005-2020 年)。
Vector Borne Zoonotic Dis. 2023 Apr;23(4):172-194. doi: 10.1089/vbz.2022.0070.
4
Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.欧盟和欧洲经济区莱姆病的监测视角
Euro Surveill. 2017 Jul 6;22(27). doi: 10.2807/1560-7917.ES.2017.22.27.30569.
5
Incidence of Lyme Borreliosis in Finland: Exploring Observed Trends Over Time Using Public Surveillance Data, 2015-2020.芬兰莱姆病的发病率:利用公共监测数据探索 2015-2020 年的时间趋势
Vector Borne Zoonotic Dis. 2023 Apr;23(4):256-264. doi: 10.1089/vbz.2022.0047. Epub 2023 Jan 27.
6
Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012.2009 - 2012年德国东部六个联邦州人类莱姆病监测数据趋势
Ticks Tick Borne Dis. 2014 Apr;5(3):219-24. doi: 10.1016/j.ttbdis.2013.10.010. Epub 2014 Mar 19.
7
Comparison of the epidemiological patterns of Lyme borreliosis and tick-borne encephalitis in the Czech Republic in 2007-2016.2007 - 2016年捷克共和国莱姆病和蜱传脑炎流行病学模式比较
Epidemiol Mikrobiol Imunol. 2018 Winter;67(3):134-140.
8
An estimate of Lyme borreliosis incidence in Western Europe†.西欧莱姆病螺旋体病发病率的估计†
J Public Health (Oxf). 2017 Mar 1;39(1):74-81. doi: 10.1093/pubmed/fdw017.
9
Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015-2017.结合初级保健监测和荟萃分析估计 2015-2017 年比利时莱姆病临床症状的发病率。
Ticks Tick Borne Dis. 2019 Apr;10(3):598-605. doi: 10.1016/j.ttbdis.2018.12.007. Epub 2018 Dec 28.
10
The Incidence of Lyme Borreliosis Among Children.儿童莱姆病螺旋体病的发病率。
Pediatr Infect Dis J. 2023 Oct 1;42(10):867-874. doi: 10.1097/INF.0000000000004040. Epub 2023 Jul 3.

引用本文的文献

1
Differential Exposure to spp. and Spotted Fever Group in Serbia and North Macedonia: A Comparative Study.塞尔维亚和北马其顿对 spp. 和斑点热群的差异暴露:一项比较研究。
Pathogens. 2025 Aug 17;14(8):814. doi: 10.3390/pathogens14080814.
2
Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey study.影响欧洲莱姆病风险认知的因素:一项横断面多国调查研究。
BMC Public Health. 2025 Aug 1;25(1):2603. doi: 10.1186/s12889-025-23722-z.
3
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome.

本文引用的文献

1
Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody.用一种人源化单克隆抗体阻断感染的硬蜱向非人灵长类传播伯氏疏螺旋体。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI144843.
2
Leveraging data visualization and a statewide health information exchange to support COVID-19 surveillance and response: Application of public health informatics.利用数据可视化和全州范围的健康信息交换来支持 COVID-19 监测和应对:公共卫生信息学的应用。
J Am Med Inform Assoc. 2021 Jul 14;28(7):1363-1373. doi: 10.1093/jamia/ocab004.
3
Lyme borreliosis: diagnosis and management.
用于治疗莱姆病后综合征的低剂量双硫仑直肠栓剂的研发。
Pharmaceutics. 2025 Jun 28;17(7):849. doi: 10.3390/pharmaceutics17070849.
4
Twenty Years of Lyme Borreliosis in the Netherlands: Temporal Trends in Seroprevalence and Risk Factors.荷兰莱姆病螺旋体病二十年:血清阳性率的时间趋势及风险因素
Microorganisms. 2024 Oct 30;12(11):2185. doi: 10.3390/microorganisms12112185.
5
Exploratory actor mapping of social interactions within tick risk surveillance networks in France.法国蜱虫风险监测网络内社会互动的探索性参与者映射
Curr Res Parasitol Vector Borne Dis. 2024 Oct 10;6:100222. doi: 10.1016/j.crpvbd.2024.100222. eCollection 2024.
6
The Role of Environmental Factors in Lyme Disease Transmission in the European Union: A Systematic Review.环境因素在欧盟莱姆病传播中的作用:一项系统综述。
Trop Med Infect Dis. 2024 May 15;9(5):113. doi: 10.3390/tropicalmed9050113.
7
Aseptic Meningitis Linked to Seroconversion in Northeastern Greece: An Emerging Infectious Disease Contested in the Region.希腊东北部无菌性脑膜炎与血清转化有关:该地区一种新出现的传染病引发争议。
Trop Med Infect Dis. 2024 Jan 19;9(1):25. doi: 10.3390/tropicalmed9010025.
8
A social-ecological systems approach to tick bite and tick-borne disease risk management: Exploring collective action in the Occitanie region in southern France.一种用于蜱虫叮咬和蜱传疾病风险管理的社会生态系统方法:探索法国南部奥克西塔尼地区的集体行动。
One Health. 2023 Sep 21;17:100630. doi: 10.1016/j.onehlt.2023.100630. eCollection 2023 Dec.
9
Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021.2021年波兰卢布林有症状莱姆病病例的估计发病率
Microorganisms. 2023 Oct 3;11(10):2481. doi: 10.3390/microorganisms11102481.
10
Emergency Department Syndromic Surveillance to Monitor Tick-Borne Diseases: A 6-Year Small-Area Analysis in Northeastern Italy.急诊科症状监测以监测蜱传疾病:意大利东北部的一项为期6年的小区域分析
Int J Environ Res Public Health. 2023 Sep 25;20(19):6822. doi: 10.3390/ijerph20196822.
莱姆病:诊断与管理。
BMJ. 2020 May 26;369:m1041. doi: 10.1136/bmj.m1041.
4
Protective Immunity and New Vaccines for Lyme Disease.莱姆病的保护性免疫与新型疫苗。
Clin Infect Dis. 2020 Apr 10;70(8):1768-1773. doi: 10.1093/cid/ciz872.
5
Introducing EU-wide surveillance of Lyme neuroborreliosis.引入全欧盟范围的莱姆病神经伯氏疏螺旋体病监测。
Lancet. 2018 Aug 11;392(10146):452. doi: 10.1016/S0140-6736(18)31738-0. Epub 2018 Aug 9.
6
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.新型莱姆病疫苗VLA15对表达六种不同OspA血清型的疏螺旋体物种具有广泛的保护作用。
PLoS One. 2017 Sep 1;12(9):e0184357. doi: 10.1371/journal.pone.0184357. eCollection 2017.
7
Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.欧盟和欧洲经济区莱姆病的监测视角
Euro Surveill. 2017 Jul 6;22(27). doi: 10.2807/1560-7917.ES.2017.22.27.30569.
8
Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation.公共卫生监测系统:使用和评估的最新进展。
Annu Rev Public Health. 2017 Mar 20;38:57-79. doi: 10.1146/annurev-publhealth-031816-044348. Epub 2016 Dec 15.
9
An estimate of Lyme borreliosis incidence in Western Europe†.西欧莱姆病螺旋体病发病率的估计†
J Public Health (Oxf). 2017 Mar 1;39(1):74-81. doi: 10.1093/pubmed/fdw017.
10
Lyme borreliosis.莱姆病。
Lancet. 2012 Feb 4;379(9814):461-73. doi: 10.1016/S0140-6736(11)60103-7. Epub 2011 Sep 6.